Harvard Bioscience announced the resignation of Michael Rossi, the Company’s CFO and treasurer, effective December 31, 2022. The Company has appointed Jennifer Cote, the Company’s vice president of global finance, as its interim CFO and treasurer, effective upon Mr. Rossi’s resignation. Mr. Rossi will remain with the Company through May 10, 2023 to provide transition assistance. The Company has initiated a search for a permanent replacement.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HBIO: